Kyowa Kirin Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$127.57 | $130.51 | 12.10% | 11 | $323.11B |
| ROG | Roche Holding | Hold |
16
|
CHF218.50 | CHF307.83 | 24.71% | 9 | CHF176.21B |
| SAN | Sanofi | Outperform |
16
|
91.02€ | 102.80€ | 19.75% | 9 | 113.65€B |
| GSK | GSK | Outperform |
12
|
£17.34 | £17.30 | 12.46% | 12 | £70.69B |
| SGEN | Seattle Genetics Inc | - |
16
|
$228.74 | $225.41 | 0.11% | 1 | $43.15B |
| BHC | Bausch Health Companies | Hold |
15
|
$7.52 | $9.50 | 26.33% | 5 | $3.21B |
| 600267 | Zhejiang Hisun Pharmaceutical | Hold |
11
|
¥7.87 | ¥15.60 | 5.46% | 0 | ¥13.66B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$30.42 | $41.00 | 31.49% | 0 | $1.69B |
| URGN | UroGen Pharma | Outperform |
6
|
$13.85 | $39.00 | 196.03% | 4 | $471.57M |
| HRTX | Heron Therapeutics | Buy |
7
|
$2.84 | $5.63 | 128.87% | 0 | $349.48M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $15.89M |